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Nr4a reporter mice are useful tools for
studying TCR signaling. Jennings et al.
show that Nr4a3, but not Nr4a1, is NFAT
pathway dependent, resulting in
restricted Nr4a3-Timer expression during
T cell development. Nr4a3-Timer requires
stronger and/or longer TCR signals than
Nr4a1-GFP, allowing an investigation of
different TCR signaling grades in vivo.ll
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https://doi.org/10.1016/j.celrep.2020.108328SUMMARYNr4a receptors are activated by T cell receptor (TCR) signaling and play key roles in T cell differentiation.
Which TCR signaling pathways regulate Nr4a receptors and their sensitivities to TCR signal strength and
duration remains unclear. Using Nr4a1/Nur77-GFP and Nr4a3-Timer of cell kinetics and activity (Tocky)
mice, we elucidate the signaling pathways governing Nr4a receptor expression. We reveal that Nr4a1–
Nr4a3 are Src family kinase dependent. Moreover, Nr4a2 and Nr4a3 are attenuated by calcineurin inhibitors
and bind nuclear factor of activated T cells 1 (NFAT1), highlighting a necessary and sufficient role for NFAT1 in
the control of Nr4a2 and Nr4a3, but redundancy for Nr4a1. Nr4a1-GFP is activated by tonic and cognate sig-
nals during T cell development, whereas Nr4a3-Tocky requires cognate peptide:major histocompatibility
complex (MHC) interactions for expression. Compared to Nr4a3-Tocky, Nr4a1-GFP is approximately 2- to
3-fold more sensitive to TCR signaling and is detectable by shorter periods of TCR signaling. These findings
suggest that TCR signal duration may be an underappreciated aspect influencing the developmental fate of
T cells in vivo.INTRODUCTION
The Nr4a family of orphan nuclear receptors consists of three
members: Nr4a1 (Nur77), Nr4a2 (Nurr1), and Nr4a3 (Nor1).
Nr4a receptors are ligand independent and their structure is
set to a constitutively active form (Wang et al., 2003). Nr4a1
and Nr4a3 are rapidly upregulated in T cells (Ashouri and Weiss,
2017; Bending et al., 2018b; Moran et al., 2011; Zikherman et al.,
2012) and thymocytes (Cheng et al., 1997), following T cell re-
ceptor (TCR) signaling, and are a more specific marker of T cell
activation than CD69, which is upregulated by non-TCR stimuli
(Moran et al., 2011). Expression of Nr4a1 (Moran et al., 2011)
and Nr4a3 (Bending et al., 2018b) in CD4+ T cells is lost in major
histocompatibility complex (MHC) class II knockout mice, high-
lighting the key role of TCR signaling in regulating Nr4a receptor
expression.
Nr4a receptors play important roles in T cell biology. The
Nr4a1 protein drives apoptosis (Liu et al., 1994) by associating
with Bcl-2 in the mitochondria (Thompson and Winoto, 2008)
and can modulate regulatory T cell (Treg) differentiation and
clonal deletion (Fassett et al., 2012). Nr4a2 binds Foxp3 regula-C
This is an open access article undtory elements and regulates the differentiation of CD4+ T cells
(Sekiya et al., 2011); and persistent Nr4a3 expression is a hall-
mark of Treg undergoing differentiation (Bending et al., 2018b).
Genetic ablation of all Nr4a receptors abolishes Treg develop-
ment and can lead to autoimmunity (Sekiya et al., 2013). Recent
studies report that nuclear factor of activated T cells (NFAT)
(Martinez et al., 2015) and Nr4a receptors (Mognol et al., 2017;
Scott-Browne et al., 2016) are linked to CD8+ T cell exhaustion.
Indeed, Nr4a family members limit chimeric antigen receptor
(CAR) T cell function (Chen et al., 2019) and Nr4a1 drives T cell
dysfunction through modulating activator protein one (AP-1)
transcription factor activity (Liu et al., 2019). Nr4a receptors
also promote CD8+ T cell exhaustion through cooperation with
other transcription factors, such as thymocyte-selection-associ-
ated high mobility group box protein (TOX) and TOX2 (Seo et al.,
2019). In addition, Nr4a1 alters T cell metabolism, acting as a
break to dampen inflammation (Liebmann et al., 2018).
Given the central roles of Nr4a members in autoimmunity and
cancer, they are an emerging therapeutic target. Pharmacolog-
ical inhibition of Nr4a receptors enhances antitumor immunity
(Hibino et al., 2018). Therefore, understanding the regulation ofell Reports 33, 108328, November 3, 2020 ª 2020 The Author(s). 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Nr4a members are paralogs, but the signaling pathways that
regulate their expression are ill defined; however, NFAT1 is
linked to their function (Martinez et al., 2015; Mognol et al.,
2017; Scott-Browne et al., 2016). Furthermore, how TCR signal
strength and duration modulate their expression is unknown.
Here, we use Nr4a3-Timer of cell kinetics and activity (Tocky)
(Bending et al., 2018a; Bending et al., 2018b) and Nr4a1/
Nur77-GFP mice (Moran et al., 2011) to determine the pathways
regulating Nr4a1 and Nr4a3 transcription in T cells. Our findings
highlight that the calcineurin (CaN)/NFAT pathway is necessary
and sufficient for the induction ofNr4a2 andNr4a3 but redundant
for Nr4a1. Moreover, although Nr4a1 is activated in response to
basal TCR signaling during lymphocyte development, Nr4a3
activation in mature T cells requires a longer TCR signaling
period that is achieved only through activating TCR signaling.
RESULTS
Nr4a Receptors Bind NFAT1 but Only Nr4a2 and Nr4a3
Are Calcineurin Pathway Dependent
Nr4a3-Tocky mice were crossed with Tg4 Tiger mice (Burton
et al., 2014), which express an autoreactive CD4+ TCR specific
for myelin basic protein (MBP) (Liu et al., 1995). This system al-
lows an analysis of TCR signaling in response to self-agonist
peptides (Figure S1A). In addition, to study CD8+ T cells,
Nr4a3-Tocky mice were bred to OTI mice (Hogquist et al.,
1994; Figure S1B). Stimulation of splenocytes with MBP Ac1-9
[4Y] peptide (Tg4) or ova peptide (OTI) triggered Nr4a3 expres-
sion, resulting in Blue fluorescence, before time-dependent
maturation to a Blue+Red+ state (Figures 1A and 1B). Expression
ofNr4a3was dependent on the Src family kinases because incu-
bation of Tg4 Nr4a3-Tocky T cells with the inhibitor PP2 (Hanke
et al., 1996) abolished Nr4a3 and CD69 (Figures 1C and 1D).
TCR signaling results in the activation of many signaling inter-
mediaries but converge on the activation of three key transcrip-
tion factors: NFAT, AP1, and nuclear factor kB (NF-kB) (Brownlie
and Zamoyska, 2013). Given that Nr4a receptors have been
linked to NFAT activation (Scott-Browne et al., 2016), we inves-
tigated the sensitivity of Nr4a3 to NFAT pathway inhibitors. We
used two distinct inhibitors of Calcineurin (CaN), a key enzyme
in TCR signaling that dephosphorylates NFAT in response to
Ca2+ signaling (Hogan et al., 2003). Incubation with cyclosporin
A (CsA; a fungus-derived product that forms a complex with cy-
clophilin to block the phosphatase activity of CaN; Liu et al.,
1991; Matsuda and Koyasu, 2000) or FK506 (amacrolide CaN in-
hibitor; Thomson et al., 1995) attenuated TCR-stimulation-
induced Nr4a3-Timer Blue expression in CD4+ Tg4 T cells (Fig-
ures 1E–1G). Highly similar findings were mirrored for CD8+
T cells (Figures 1H–1J). These data suggested that Nr4a3-Tocky
is an NFAT responsive distal TCR signaling reporter.
Three isoformsofNFATareexpressed inTcells (NFAT1,NFAT2,
and NFAT4; Macian, 2005). To ascertain NFAT binding, we identi-
fied a previously published chromatin immunoprecipitation
sequencing (ChIP-seq) dataset (Gene Expression Omnibus
(GEO) GEO: GSE64409; Martinez et al., 2015) for the binding of
NFAT1 to Nr4a genes. Analysis of NFAT1 binding peaks revealed
evidence for NFAT1 binding across all Nr4a gene family members2 Cell Reports 33, 108328, November 3, 2020(Figure1K). To test the sensitivity of the otherNr4a familymembers
to CaN inhibitors, Nr4a1, Nr4a2, and Nr4a3 mRNA levels were
quantified in response to TCR stimulation. Although Nr4a2 and
Nr4a3 showed inhibition of transcriptional upregulation in
response tobothCsAandFK506,Nr4a1was insensitive toboth in-
hibitors, as has been previously reported (Zikherman et al., 2012;
Figure 1L). In order to directly compare expression in the same
cells, Nr4a3-Tocky mice were crossed with Nr4a1-GFP mice
(Moran et al., 2011) to generate a dual reporter. Splenocytes of
Nr4a1-GFP/Nr4a3-Tockymicewerestimulated for 4 hwith soluble
anti-CD3 in the presence of a range of CsA or FK506 doses (Fig-
ure 1M). Both reporters were highly expressed following stimula-
tion; Nr4a3-Tocky expression is markedly reduced at doses in
excess of 0.01 mM, whereas Nr4a1-GFP expression remained
insensitive even up to doses as high as 10mM.Therefore, although
NFAT1 binds to all Nr4a gene family members, NFAT pathway
signaling appears necessary only for the expression of Nr4a2
and Nr4a3 and is redundant for Nr4a1.
ERK Signaling Is Required for Maximal Nr4a Expression,
but Nr4a3 Can Be Activated by NFAT Overexpression
Alone
NFAT extensively co-operates with AP-1 (Jain et al., 1993; Peter-
son et al., 1996), and together they activate important genes in
response to TCR stimulation. AP-1 is dependent on mitogen-
activated protein kinase (MAPK) activity (Karin, 1995), in partic-
ular ERK pathway activation. To test the sensitivity of Nr4a3
and CD69 to ERK/AP-1 pathway inhibition, purified CD8 T cells
from Nr4a3-Tocky OTI mice were stimulated with ova peptide
in the presence of PP2, CsA, or PD0325901 (PD, an ERK
pathway inhibitor; Barrett et al., 2008). As previously shown in
bulk splenocytes, Nr4a3 and CD69 expression are rapidly upre-
gulated following stimulation. TCR-induced Nr4a3 expression
was significantly reduced by NFAT pathway inhibition and
partially reduced by ERK pathway inhibition (Figures 2A and
3B). TCR-induced CD69 expression showed partial sensitivity
to NFAT and ERK pathway inhibition and complete abolition
following inhibition of both pathways (Figures 2A and 2C).
To further analyze the kinetics ofNr4a receptor transcription in
response to TCR stimulation, a time course analysis was per-
formed on peptide-stimulated Tg4 or OTI T cells (Figures 2D
and 2E) in the presence of NFAT or ERK pathway inhibitors. Sig-
nificant inhibition of all Nr4a family member transcription by ERK
pathway inhibition occurred at 2 h post-stimulation, but there
was no significant effect of CsA on Nr4a1 transcription. In
contrast, CsA resulted in a greater repression of Nr4a2 and
Nr4a3 transcription than ERK pathway inhibition (Figures 2D
and 2E), in keeping with the analysis of Nr4a3-Timer expression
by flow cytometry (Figure 2A). OTI T cells largely mirrored Tg4
T cells in the sensitivity of Nr4a receptors to NFAT and ERK
pathway inhibitors, with all showing partial ERK dependence,
but only Nr4a2 and Nr4a3 being sensitive to CsA (Figure 2E).
UsingNr4a1-GFPmice, we confirmed that the BACNr4a1 trans-
genic reporter also showed partial sensitivity to ERK pathway in-
hibition but is insensitive to NFAT pathway inhibition (Zikherman
et al., 2012; Figure 2F). In order to rule out the possibility that the
expression ofNr4a1 could bemodulated by co-stimulation or cy-
tokines derived from antigen-presenting cells (APCs) present in
Figure 1. Nr4a Receptors Bind NFAT1, but Only Nr4a2 and Nr4a3 Are Calcineurin Pathway Dependent
(A and B) Splenocytes from Tg4 Nr4a3-Tocky mice (A) or OTI Nr4a3-Tocky mice (B) were stimulated with 10 mM 4Y-MBP before analysis by flow cytometry for
expression of Nr4a3-Timer Blue versus Nr4a3-Timer Red in live T cells.
(CandD)Splenocytes fromTg4Nr4a3-Tockymicewerestimulatedwith10mM4Y-MBP(C) orOTINr4a3-Tockywerestimulatedwith1mMovapeptide (D) for 4h in the
presence of DMSO or 10 mM PP2 before analysis by flow cytometry for Nr4a3-Timer Blue versus Nr4a3-Timer Red expression in live CD4+ (C) or CD8+ (D) T cells.
(E and F) Splenocytes from Tg4Nr4a3-Tockymicewere stimulatedwith 10 mM4Y-MBP variant for 4 h in the presence of DMSO, 1 mMcyclosporin A (CsA), or 1 mM
FK506 before analysis of Nr4a3-Time Blue versus Nr4a3-Timer Red expression in live CD4+ Tg4 T cells by flow cytometry (E). Summary data showing the %
Nr4a3-Timer Blue+ (F) or median Nr4a3-Timer Blue in live CD4+ Tg4 T cells (G); n = 4 (FK506) or n = 6 (unstim [unstimulated control], DMSO, and CsA).
(F and G) Statistical analysis by one-way ANOVA with Tukey’s multiple comparisons test. Bars represent mean ± SEM; dots represent individual mice. *p<0.05,
***p<0.001, ****p<0.0001.
(H–J) Splenocytes from OTINr4a3-Tocky mice were stimulated with 1 mMova peptide for 4 h in the presence of DMSO, 1 mMCsA, or 1 mMFK506 before analysis
of Nr4a3-Timer Blue versus Nr4a3-Timer Red expression in live CD8+ OTI T cells by flow cytometry (H). Summary data showing the % Nr4a3-Timer Blue+ (I) or
median Nr4a3-Timer Blue (J) in live CD8+ OTI T cells, n = 4.
(I and J) Statistical analysis by one-way ANOVA with Tukey’s multiple comparisons test. Bars represent mean ± SEM; dots represent individual mice.
****p<0.0001.
(K) University of California, Santa Cruz (UCSC) genome browser tracks showing NFAT1 binding peaks in P14+ Tcra/ CD8+ T cells from GEO: GSE64409.
UnstimKO, unstimulated NFAT1 knockout [KO]; Stim, phorbol myristate acetate (PMA) and ionomycin stimulation; StimKO, PMA and ionomycin stimulation in
NFAT1KO mice.
(L) Splenocytes from Tg4 Nr4a3-Tocky mice were stimulated with 5 mg/ml soluble anti-CD3 for 4 h in the presence of DMSO (), 10 mM PP2, 1 mM CsA, or 1 mM
FK506 before extraction of RNA and analysis of fold change in Nr4a receptor transcription; n = 3. Statistical analysis by one-way ANOVA with Tukey’s multiple
comparisons test. Bars represent mean ± SEM; dots represent individual mice. *p<0.05, **p<0.01, ***p<0.001.
(M) Splenocytes from Nr4a1-GFP Nr4a3-Tocky mice were stimulated with 5 mg/ml soluble anti-CD3 for 4 h in the presence of CsA or FK506. Live CD8+ T cells
were analyzed by flow cytometry for expression of Nr4a1-GFP and Nr4a3-Timer Blue. See also Figure S1.
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cells (Figures S2A). Transcript levels of Nr4a family member
genes were measured in purified Nr4a3-Tocky OTI CD8 T cells
following stimulation with peptide in the presence of inhibitors
(Figure S2B). In addition, naive CD4 and bulk CD8 T cells were
purified from Nr4a1-GFP mice and stimulated with soluble
anti-CD3 before an analysis of Nr4a1-GFP expression by flow
cytometry (Figures S2C and S2D). In both instances, our previ-
ous findings were re-capitulated.Given that NFAT:AP-1 complexes are critical to T cell activa-
tion, we investigated whether NFAT activity alone is sufficient
to drive Nr4a2 and Nr4a3 expression. In silico analysis of a pub-
lished RNA sequencing (RNA-seq) dataset of T cells expressing
constitutively active NFAT1, which was modified to abrogate its
binding to AP1 (Martinez et al., 2015; constitutively active R468,
I469 and T535 (CA-RIT)-NFAT1), revealed that CA-RIT-NFAT1
resulted in a statistically significant upregulation of Nr4a3 within
CD4 (>3-fold; Figure 2G) and CD8 T cells (>50-fold; Figure 2H)Cell Reports 33, 108328, November 3, 2020 3
Figure 2. ERK Signaling Is Required for Maximal Nr4a Expression in T Cells, but Nr4a3 Can Be Activated by NFAT Overexpression Alone
(A–C)PurifiedOTINr4a3-TockyCD8+ T cells were stimulatedwith 1 mMovapeptide for 4 h in the presence ofDMSO, 10mMPP2, 1 mMCsA, 5 mMPD0325901 (PD), or
CsA and PD. Cells were analyzed by flow cytometry for the expression of Nr4a3-Timer Blue andCD69 in live CD8+ T cells. Summary data from%Nr4a3-Timer Blue+
(B) and%CD69+ (C); n = 4. Bars represent mean ± SEM, dots represent individual donor mice. (D–E) Splenocytes from Tg4Nr4a3-Tockymice were stimulated with
10 mM4Y-MBP (D) or OTINr4a3-Tockymice with 1 mMova peptide (E) for 4 h in the presence of DMSO, 1 mMCsA, or 5 mMPD; RNAwas extracted at 0, 1, 2, and 4 h
following culture; and fold change in Nr4a1–Nr4a3 transcription was measured. DMSO treated, black circles; CsA treated, black crosses; or PD treated, open
squares; n = 4 (D); or n = 3 (E). Bars represent mean ± SEM; #, CsA treated significantly reduced (p < 0.05) from DMSO; x, PD treated significantly reduced (p < 0.05)
from DMSO; !, CsA treated significantly reduced (p < 0.05) from PD. Statistical analysis by two-way ANOVA with Tukey’s multiple comparisons test.
(F) Splenocytes from Nr4a1-GFP mice were cultured for 4 h with 5 mg/ml anti-CD3 or media alone (unstim) in the presence of 0.1% DMSO, 10 mMPP2, 1 mMCsA
or 5 mM PD, or 1 mM CsA and 5 mM PD. Live CD4+ (left) or CD8+ (right) T cells were then analyzed for Nr4a1-GFP expression.
(G and H) Analysis of RNA-seq data from GEO: GSE64409 displaying the fold change in expression of Nr4a1, Nr4a2, Nr4a3, and Cd69 in CD4+ (G) or CD8+ (H)
T cells transduced with CA-RIT-NFAT1. Adjusted p values based on DESeq analysis; *p = 0.0206, **p = 0.00305, ***p = 0.00016. See also Figure S2.
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activity alone is sufficient for the induction of Nr4a2 and Nr4a3
expression in CD8 T cells and Nr4a3 in CD4 T cells, but not
Nr4a1 and Cd69.
Nr4a1 and Nr4a3 Expression Patterns during
Lymphocyte Development
Given the differential sensitivity of Nr4a1 and Nr4a3 to TCR
signaling pathways, we interrogated their expression in Nr4a1-
GFP Nr4a3-Tocky mice. A partial quenching of the Nr4a3-Tocky
reporter was seen when the line was generated as a ‘‘heterozy-
gous’’ bacterial artificial clone (BAC) compared to ‘‘homozygous,’’
but similar patterns of expression remained (Figure S3). Thymic
T cell development analysis revealed that Nr4a1-GFP was absent
within pre-selection immature TCRblo double positive (DP) cells,
but increased in expression in the TCRbhi DP fraction, indicative4 Cell Reports 33, 108328, November 3, 2020of low-strength TCR signaling events that occur during positive
selection, such that all positively selected CD4 single positive
(SP) cells expressed Nr4a1-GFP (Figure 3A). Nr4a3 expression
was largely absent from the DP and CD4+CD25 fraction,
showing moderate expression only in Nr4a1-GFP bright cells;
however, it was highly expressed within the CD4SP CD25hi
fraction, which is enriched with Tregs (Figures 3A and 3D). A
comparison of Nr4a1-GFP and Nr4a3-Timer Red revealed how
Nr4a3-Timer expression only emerged at the highest levels of
GFP, indicating that cells may be receiving different strength/du-
rations of TCR signaling in vivo. Importantly, administration of
cognate peptide in Tg4 Nr4a3-Tocky mice elicited Nr4a3 expres-
sion in both DP and CD4SP thymocytes. This suggests that the
lack of Nr4a3 expression is not due to inaccessibility of the
Nr4a3 BAC reporter locus in thymocytes (Figure S4). In keeping
with the thymus, peripheral CD4+CD25 and CD8+ T cells
Figure 3. Nr4a1 and Nr4a3 Expression Patterns during T Cell Development in the Thymus
(A) Thymus from Nr4a1-GFP Nr4a3-Tocky mice was analyzed for expression of Nr4a1-GFP and Nr4a3-Timer Blue and Nr4a3-Timer Red expression within live
TCRblo and TCRbhi double positive (DP), CD25 and CD25+ CD4SP, and CD8SP subsets by flow cytometry.
(B–E) Splenic CD4+CD25, CD4+CD25 T cells (B) and CD8+ T cells (C) were analyzed for expression of Nr4a1-GFP and Nr4a3-Timer Blue and Nr4a3-Timer Red
expression by flow cytometry. Summary data of Nr4a1-GFP and Nr4a3-Timer expression in thymic (D) or splenic (E) T cell subsets. Bars represent mean ± SEM;
dots represent individual mice; n = 6. Data are pooled from four independent experiments. Statistical analysis by two-way ANOVA with Tukey’s multiple
comparisons tests. ***p < 0.001, ****p < 0.0001. See also Figures S3, S4, and S5.
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Nr4a3 expression. In contrast, CD4+CD25+ T cells were enriched
for Nr4a3+ T cells as previously reported (Bending et al., 2018b;
Figure 3B). In all peripheral T cell subsets, significant background
Nr4a1-GFP expression remained in non-Treg subsets (Figure 3E).
Nr4a1-GFP is also expressed in developing andmature B cells
(Moran et al., 2011; Zikherman et al., 2012). Similarly, we found
that mature B cells expressed Nr4a1, but not Nr4a3, highlighting
that tonic B cell receptor (BCR) signaling can also activate Nr4a1
but not Nr4a3 expression (Figure S5A). Furthermore, in the
spleen, marginal zone (MZ) B cells exhibited higher levels of
Nr4a1-GFP than follicular (F) B cells, despite continuing to be ab-
sent for Nr4a3-Timer expression (Figure S5B).
Nr4a1-GFP Is More Sensitive to TCR Signals and Can Be
Activated by Shorter TCR Signaling Bursts than Nr4a3-
Timer
Based on differential expression of Nr4a1 and Nr4a3 in lympho-
cytes, we hypothesized that Nr4a1 has a higher sensitivity to
TCR signaling. Indeed, it has been reported in CD4 T cells that
Nr4a3 expression has a 3-fold higher half maximal effective con-
centration (EC50) than Nr4a1 in response to peptide stimulation
(Shimizu et al., 2020). In order to verify this finding, we stimulated
Nr4a1-GFP Nr4a3-Tocky splenocytes with a dose titration of
soluble anti-CD3 for 4 h (Figure 4A). Dose-response curves of
Nr4a1-GFP andNr4a3-Timer expression showed that the propor-
tion of Nr4a1-GFP+ T cells increased at lower doses than Nr4a3-
Blue+ T cells (Figures 4B and 4C). EC50 values were calculated
following data normalization, revealing a 2.9-fold difference in
EC50 between Nr4a1-GFP and Nr4a3-Blue for CD8s (Figure 4C).
This increased sensitivity of Nr4a1 to TCR signals, however,
seemed insufficient to explain the disparity between thymicNr4a1-GFP and Nr4a3-Timer expression. Given that Nr4a3 is
highly expressed in thymic CD25+ Treg cells (Figures 3A and
3D) and our previous findings that thymic Tregs persistently ex-
press Nr4a3 (Bending et al., 2018b), we hypothesized that TCR
signal duration may determine Nr4a1-GFP and Nr4a3-Timer
expression. We modulated the length of TCR signaling in vitro
by stimulating Nr4a1-GFP Nr4a3-Tocky splenocytes with anti-
CD3 and then terminating TCR signaling through pharmacolog-
ical inhibition with PP2 (Figure 4D). Following termination of TCR
signaling, T cells remained in culture for 4 h to allow time for
translation of the reporter proteins and their accumulation (Fig-
ures 4D–4F). The proportion of Nr4a1-GFP-expressing cells
increased after 5 min of stimulation, reaching a maximum
response at 1 h. The proportion of Nr4a3-expressing cells did
not increase until 30 min and did not reach maximum until 4 h
(Figures 4E and 4F; time to half of maximum [T1/2] Nr4a1 =
12 min, T1/2 Nr4a3 = 70 min). Differential sensitivity of Nr4a1-
GFP and Nr4a3-Tocky to TCR signaling duration suggests that
TCR signaling events in the thymus that lead to thymic Treg
development must persist for >60 min, whereas positive selec-
tion events may be as short as 15 min.
Peptide Affinity Has Only a Modest Effect on the
Threshold for Nr4a3 Activation Compared to Nr4a1
In order to investigate how expression levels of Nr4a1 and Nr4a3
differ in response to different TCR affinities, Nr4a1-GFP Nr4a3-
Tocky mice were crossed with OTI mice. As expected, we
observed expression of Nr4a1-GFP, but not Nr4a3-Timer, in
TCRb+ DP and CD8SP thymocytes (Figures 5A and 5B).
Nr4a1-GFP Nr4a3-Tocky OTI splenocytes were stimulated with
a range of doses of different affinity ova peptides (Figure 5C).
Higher affinity peptides N4 (Figure 5D) and Q4 (Figure 5E)Cell Reports 33, 108328, November 3, 2020 5
Figure 4. Nr4a1 Is More Sensitive to TCR Signals and Can Be Activated by Shorter TCR Signaling Bursts than Nr4a3
(A) Nr4a1-GFPNr4a3-Tocky splenocytes were cultured with soluble anti-CD3 for 4 h before analysis of live CD8+ T cells for expression of Nr4a1-GFP and Nr4a3-
Timer Blue.
(B) Summary showing the raw % of CD8+ T cells in response to anti-CD3; n = 5, bars represent mean ± SEM.
(C) Normalized responses of Nr4a1-GFP and Nr4a3-Timer Blue to anti-CD3; n = 5, bars represent mean ± SD. EC50 values and 95% confidence intervals (CIs) are
stated.
(D) Nr4a1-GFP Nr4a3-Tocky splenocytes were stimulated with 5 mg/ml anti-CD3 for 4 h. At the indicated time points, PP2 was added at a final concentration of
10 mM. After 4 h of culture, cells were analyzed for Nr4a1-GFP and Nr4a3-Timer Blue expression in live CD8+ T cells by flow cytometry.
(E) Summary data showing the raw%of CD8+ T cells for Nr4a1-GFP or Nr4a3-Timer Blue in response to the period of TCR signaling; bars represent mean ± SEM,
n = 3.
(F) Summary data showing normalized response for Nr4a1-GFP or Nr4a3-Timer Blue in response to the period of TCR signaling; bars represent mean ± SEM,
n = 3. *, indicates significant differences (p < 0.05) between Nr4a1-GFP and Nr4a3-Timer Blue for 2.5-, 5-, 10-, 15-, 30-, and 60-min time points (analysis by
two-way ANOVA with Tukey’s multiple comparisons test). Data are pooled from three independent experiments.
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OPEN ACCESStriggered expression of both Nr4a1-GFP and Nr4a3-Timer at
lower doses. Dose-response curves of Nr4a1-GFP and Nr4a3-
Timer expression in response to N4 cognate peptide stimulation
demonstrated only very minor differences in EC50. In contrast,
stimulation with the V4 peptide demonstrated a 3.5-fold differ-
ence in EC50, and even at saturating doses, <90% of cells
were positive for the Nr4a3 reporter and plateaued before
reaching 100% of the normalized response to the N4 peptide
(Figure 5F). Taken together, these data demonstrate that
Nr4a1-GFP and Nr4a3-Tocky reporters are regulated by distinct
pathways downstream of the TCR and their expression patterns
differ due to differential sensitivities to TCR signal strength and
duration.
DISCUSSION
The data have highlighted how the differential sensitivities of
Nr4a1 and Nr4a3 to distal TCR signaling pathways can be ex-6 Cell Reports 33, 108328, November 3, 2020ploited to identify T cells undergoing different types of TCR
signaling in vivo. Nr4a1 exhibits a lower threshold for activation
in terms of both strength and time required for TCR signaling
to elicit its activation. Our data would suggest that Nr4a1-GFP
expression can be triggered by short-lived antigen receptor sig-
nals, whereas Nr4a3-Timer requires full activation of the NFAT
pathway. Nr4a1-GFP expression persists in the periphery, and
it is unclear as to what extent this expression is due to residual
GFP from selection events in the thymus versus the continued
recognition of MHC in the periphery. Given that Tregs continue
to express Nr4a3 in the periphery, this would suggest that Tregs
continue to undergo signals that cross the threshold for NFAT
activation outside the thymus.
Nr4a receptors are emerging as an exciting target for immu-
nomodulation (Flemming, 2019), in particular as a potential
strategy to fine-tune CAR T cell attack of solid tumors (Li and
Zhang, 2019). Here, we have shown that Nr4a1, Nr4a2, and
Nr4a3 are distinctly regulated by the CaN/NFAT pathway but
Figure 5. Peptide Affinity Has Only a Modest Effect on the Threshold for Nr4a3 Activation Compared to Nr4a1
(A) Thymus from OTI Nr4a1-GFP Nr4a3-Tocky mice displaying CD4 versus CD8 (left), CD8 versus TCR-beta in DP cells (middle), or CD8SP (right) populations.
(B) Histogram overlays of Nr4a1-GFP expression (left), Nr4a3-Timer Blue (middle), or Nr4a3-Timer Red (right) in the thymic or splenic populations indicated.
(C) Splenocytes from OTI Nr4a1-GFP Nr4a3-Tocky mice were cultured for 5 h in the presence of a dose range of ova peptide variants (concentrations shown are
mM scale). N4 (SIINFEKL), Q4 (SIIQFEKL), or V4 (SIIVFEKL). Summary data of N4 (D), Q4 (E), or V4 (F) responses from (C) for Nr4a1-GFP (green) or Nr4a3-Timer
Blue (blue) as raw% (bars represent mean ± SEM) of CD8+ T cells (left) or normalized response (right). EC50 values are calculated from curve fitting of normalized
data. Data are from two independent experiments.
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expression in response to TCR stimulation. Interestingly, an
analysis of NR4A1 protein regulation in human T cells has
shown that they are also insensitive to CaN inhibitors (Ashouri
andWeiss, 2017) but show a partial ERK dependence, suggest-
ing that regulation of Nr4a1 may be conserved between mice
and humans. Nr4a3 has been shown to be regulated by the
MAPK/ERK pathway in response to platelet-derived growth
factor in vascular smooth muscle cells (Nomiyama et al.,
2006). Similarly, in ovarian cells, calcium-dependent activation
of ERK mediates AP-1 induction of Nr4a1 (Stocco et al., 2002),
establishing a common link between ERK signaling and the
regulation of Nr4a receptor expression across diverse tissue
types.
Despite being insensitive to CaN inhibitors, the Nr4a1 gene
region exhibited binding of NFAT1. Surprisingly, both cyclo-
sporin and FK506 had no effect on the transcriptional dynamics
ofNr4a1 expression in response to peptide stimulation of either
CD4+ and CD8+ T cells. This finding could represent redun-
dancy in the regulation of Nr4a1 by NFAT1, given that Nr4a1appears more sensitive to a broad range of distal TCR signaling
pathways. In particular, it has been previously observed that
cyclosporin may interfere with Nr4a1 biology at the level of its
DNA binding activity through its N-terminal protein region (Yaz-
danbakhsh et al., 1995), without interfering with its transcrip-
tion. In this way, cyclosporin may abrogate the biological
effects of all Nr4a receptors through disparate mechanisms of
action. On the other hand, constitutively active NFAT1 did not
significantly alter Nr4a1 expression in CD4+ or CD8+ T cells
transduced with the CA-RIT-NFAT1 vector, suggesting that
Nr4a1 cannot be activated by NFAT1 activity alone. However,
as the CA-RIT-NFAT1 construct is incapable of binding AP-1
(Martinez et al., 2015), it is still possible that NFAT:AP1 com-
plexes could redundantly activate Nr4a1 or that NFAT2 and
NFAT4 may substitute.
PP2 inhibitor data suggest that Nr4a induction is triggered by
the activity of lymphocyte-specific protein tyrosine kinase (Lck).
Lck associates with the cytoplasmic tails of CD4 and CD8 co-
receptors (Veillette et al., 1988). Peptide-MHC engagement of
the TCR leads to Lck-mediated phosphorylation of the TCRCell Reports 33, 108328, November 3, 2020 7
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OPEN ACCESSand CD3 chains (Straus and Weiss, 1992). Interestingly, past
work has suggested that more CD4 co-receptors are loaded
than CD8 molecules, which can affect the dwell time of T cells
(Stepanek et al., 2014). Our comparison of Nr4a transcriptional
dynamics suggested that CD8+ T cells receive an initial shorter,
sharper, and stronger activation of Nr4a transcription, which
peaks at 1 h. Interestingly, Nr4a receptor transcription in CD4+
T cell peaked around 2 h and appeared to plateau, suggesting
potential subtle differences in distal TCR signaling dynamics be-
tween CD4+ and CD8+ T cells.
Nr4a1 GFP transgenic reporters (Moran et al., 2011; Zikher-
man et al., 2012) have been useful tools to study Treg and
invariant natural killer T (iNKT) cell development, as well as to
address B cell activation to antigen. However, as previously
alluded to, temporal analysis of Nr4a1-GFP reporters may be
hampered by the persistence of GFP expression following anti-
gen encounter (Au-Yeung et al., 2014). The Nr4a3-Tocky system
used in this study does not suffer from this same issue because
the half-life of the Timer Blue protein is 4 h (Bending et al.,
2018b), allowing a sensitive readout over much shorter time
frames. Given that NFAT in the absence of AP-1 induces a
chronic T cell exhaustion phenotype (Martinez et al., 2015),
Nr4a3-Tocky will be useful tools for understanding NFAT
pathway activity in models of T cell dysfunction and cancer.
Furthermore, assessing Nr4a3 and Nr4a1 co-regulation will be
a potent tool to interrogate alterations in TCR signaling in vivo.
The finding that Nr4a1-GFP can be rapidly expressed in
response to minutes of TCR signaling suggests that caution
should be used when using it as a readout of TCR signal
strength; moreover, an accumulation of GFP appears to be an
event that is time dependent, and therefore, different levels of
GFP may reflect different durations of TCR signals. Indeed, an
analysis of mice using the markers CD5, Ly6C, and Nr4a1-GFP
have shown that a broad range exists in vivo for naive T cells
even within the same TCR niche (Zinzow-Kramer et al., 2019).
These findings suggest that conventional T cells likely continue
to receive sporadic short-lived signals in the periphery but that
Tregs undergo full and frequent NFAT pathway activation.
A potential limitation of the study is that we cannot exclude the
possibility that differential sensitivity of flow cytometers to detect
GFP versus Timer protein could contribute to the failure to detect
T cells expressing low levels of Nr4a3. It is possible that the vari-
ation in BAC copy number between the systems could also influ-
ence the sensitivity of the reporters. In order to test this,Nr4a1 and
Nr4a3 BACGFP reporters with known copy numbers would need
to be compared head to head. However, in terms of quantum
yield, calculations for Timer Blue are in the range 0.30–0.41 (Sub-
ach et al., 2009), which is comparable to EGFP (0.60; Ilagan et al.,
2010). Additionally, in our comparison of signal duration, for which
we pharmacologically inhibited TCR signaling (Figure 4D), we left
the cells in culture for 4 h to allow for differences in folding and
fluorescence of the proteins. This means that we maximized our
ability to detect the presence of any fluorescent proteins that
would have accumulated in response to the initial signal.
In summary, our findings highlight the distinct sensitivity of
Nr4a family members to the NFAT pathway. Shorter and weaker
TCR signals elicit Nr4a1-GFP expression in response to TCR
signaling during lymphocyte development. Sustained TCR8 Cell Reports 33, 108328, November 3, 2020signaling is required for Nr4a3-Timer expression, highlighting
that signal duration should also be considered in relation to
signal strength when interpreting TCR signaling using Nr4a
receptor reporter mice.
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Seo, H., Chen, J., González-Avalos, E., Samaniego-Castruita, D., Das, A.,
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Antibodies
Anti CD4 AF700 Rat monoclonal RM4-4 BioLegend Cat# 116022; RRID: AB_2715957
Anti CD4 BUV737 Rat monoclonal GK1.5 BDBiosciences Cat# 564298; RRID: AB_2738734
Anti TCRVb 8.1/8.2 PerCP-eFluor710 Rat
monoclonal KJ16-133
ThermoFisher Cat# 46-5813-82; RRID: AB_10549113
Anti TCRVb 8.1/8.2 BUV395 Rat monoclonal
MR5-2
BDBiosciences Cat# 744335; RRID: AB_2742163
Anti TCRb AF700 Armenian Hamster
monoclonal H57-597
BioLegend Cat# 109223; RRID: AB_109223
Anti CD69 APC Armenian Hamster
monoclonal H1.2F3
BioLegend Cat# 104513; RRID: AB_492844
Anti CD8 AF700 Rat monoclonal 53-6.7 BioLegend Cat# 100729; RRID: AB_493702
Anti CD8 BUV395 Rat monoclonal 53-6.7 BDBiosciences Cat# 563786; RRID: AB_2732919
Anti TCR Va2 PerCP/Cyanine5.5 Rat
monoclonal B20.1
BioLegend Cat# 127813; RRID: AB_1186118
Anti TCR Vb5.1/5.2 APC Mouse monoclonal MR9-4 BioLegend Cat# 139505; RRID: AB_10897800
Anti B220 PerCP-Cy5.5 Rat monoclonal RA3-6B2 BDBiosciences Cat# 561101; RRID: AB_10565970
Anti CD43 Biotin Rat monoclonal S7 BDBiosciences Cat# 553269; RRID: AB_2255226
Anti IgM PE-Cy7 Rat monoclonal RMM-1 BioLegend Cat# 406513; RRID AB_10640069
Anti IgD APC Rat monoclonal 11-26C Invitrogen Cat# 17-5993-82; RRID: AB_10598660
Anti CD21 APC Rat monoclonal 7G6 BDBiosciences Cat# 561770; RRID: AB_10892818
Anti CD23 PE-Cy7 Rat monoclonal B3B4 ThermoFisher Cat# 25-0232-82; RRID: AB_469604
Anti CD25 PerCP/Cy5.5 Rat monoclonal PC61 BioLegend Cat# 102029; RRID: AB_893291
Anti CD19 BUV737 Rat monoclonal 1D3 BDBiosciences Cat# 564296; RRID: AB_2716855
Anti CD3ε Armenian Hamster monoclonal 145-2C11 BioLegend Cat# 100301; RRID: AB_312666
Chemicals, Peptides, and Recombinant Proteins
Streptavidin BV711 BioLegend Cat# 405241
MBP Ac1-9[4Y] peptide AcASQYRPSQR GL Biochem Shanghai Custom product
N4 OVA 257-264 SIINFEKL peptide GL Biochem Shanghai Cat# 181660
Q4 OVA 257-264 SIIQFEKL peptide GL Biochem Shanghai Cat# 151560
V4 OVA 257-264 SIIVFEKL peptide GL Biochem Shanghai Cat# 151561
Cyclosporin A Cell Guidance Systems Cat# SM43; CAS: 59865-13-3
FK506 (Tacrolimus) Cayman Chemical Cat# 10007965; CAS: 59865-13-3
PD 0325901 Cayman Chemical Cat# 13034; CAS: 391210-10-9
DMSO Sigma Aldrich Cat# D2650; CAS: 67-68-5
PP2 Sigma Aldrich Cat# P0042; CAS: 172889-27-9
Critical Commercial Assays
RNeasy mini kit QIAGEN Cat# 74104
Invitrogen Superscript IV Reverse Transcriptase ThermoFisher Cat# 18090050
Invitrogen Random hexamers ThermoFisher Cat# N8080127
Applied Biosystems SYBR green power up master mix ThermoFisher Cat# A25752
eFluor-780 fixable viability dye eBioscience Cat# 65-0865-14
MoJo Sort nanobeads: CD8 T Cell Isolation Kit BioLegend Cat# 480035
MoJo Sort nanobeads: naive CD4 T Cell Isolation Kit BioLegend Cat# 480039
(Continued on next page)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Deposited Data
RNA-seq of CA-RIT-NFAT1 CD8 T cells, NFAT1
ChIP-seq of WT and NFAT/ CD8 T cells
Martinez et al., 2015 GEO: GSE64409
Experimental Models: Organisms/Strains
Mouse: Nr4a3-Tocky founder line 323 Bending et al., 2018b;
Obtained from Dr. Masahiro
Ono from Imperial College
London under MTA
PMID: 29941474
Mouse:Tg4-H2U Liu et al., 1995; Provided by
Prof. David Wraith University
of Birmingham
PMID: 7584132
Mouse: IL-10-GFP Tiger Kamanaka et al., 2006;




Mouse: Great-Smart17A Price et al., 2012; Obtained
from Prof. Richard Locksley
from University of California,
San Francisco under MTA
PMID: 22768117
Mouse: Nr4a1/Nur77-GFP Moran et al., 2011; Provided
by Prof. Graham Anderson
University of Birmingham
PMID: 21606508




Bending et al., 2018a PMID: 29991564
Nr4a1 for: TGTGAGGGCTGCAAGGGCTTC
rev: AAGCGGCAGAACTGGCAGCGG
Sekiya et al., 2013 PMID: 23334790
Nr4a2 for: CTGTGCGCTGTTTGCGGTGAC
rev: CGGCGCTTGTCCACTGGGCAG
Sekiya et al., 2013 PMID: 23334790
Nr4a3 for: AGGGCTTCTTCAAGAGAACGG
rev: CCATCCCGACACTGAGACAC




GraphPad Prism 7 and 8 https://www.graphpad.com/scientific-
software/prism/
FlowJo v10.5.3 https://www.flowjo.com/solutions/flowjo
CyVerse Discovery Environment https://cyverse.org/discovery-environment





Further information and requests for resource and reagents should be directed to and will be fulfilled by the Lead Contact Dr. David
Bending (d.a.bending@bham.ac.uk).
Materials Availability
This study did not generate new unique reagents. Nr4a3-Tocky mice are available from Dr. M. Ono, Imperial College London, under
material transfer agreement (MTA). Great Smart-17A mice are available from Prof. R. Locksley, UCSF under MTA.
Data and Code Availability
This article includes analysis of previously published datasets: RNA-seq of CA-RIT-NFAT1 CD8 T cells, NFAT1 ChIP-seq of WT and
NFAT1/ CD8 T cells – GEO: GSE64409, (Martinez et al., 2015).e2 Cell Reports 33, 108328, November 3, 2020
Report
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OPEN ACCESSEXPERIMENTAL MODEL AND SUBJECT DETAILS
All animal experiments were performed in accordancewith local AnimalWelfare and Ethical ReviewBody at theUniversity of Birming-
ham and under the authority of a Home Office project license, P18A892E0A held by D.B. Animals were housed in specific pathogen-
free conditions with appropriate housing conditions and husbandry as specified by NC3Rs. Genotypes of transgenic mice were
confirmed by end point PCR of ear skin samples and agarose gel electrophoresis. Male and female mice were used, littermates
of the same sex were randomly assigned to experimental groups.
Nr4a3-Tocky Mice
Nr4a3-Tockymice expressing aBAC containing FT FastmCherrymutant (Subach et al., 2009) under the influence ofNr4a3 regulatory
regions on the C57BL/6J background as previously described (Bending et al., 2018b), were obtained fromDr. Masahiro Ono, Imperial
College London, under MTA.
Tg4 TCR Transgenic Mice
Tg4 mice expressing the ab TCR (Va4, Vb8.2) of the MBP Ac1-9-specific hybridoma 1934.4 (Liu et al., 1995).
IL-10-GFP Tiger Mice
IL-10-GFP Tiger mice expressing an IRES GFP transgene inserted into the Il10 locus on the C57BL/6 background as previously
described (Kamanaka et al., 2006).
Great-Smart17A Mice
Great-Smart17A expressing an IRES YFP transgene inserted into the Ifng locus and an IRES hNGFR transgene inserted into the Il17A
locus as previously described (Price et al., 2012). Great-Smart-17A mice were obtained from Prof. Richard Locksley, UCSF, under
MTA.
Nr4a1/Nur77-GFP Mice
Nr4a1/Nur77-GFP mice expressing a BAC containing GFP transgene under the influence of Nr4a1 regulatory regions on C57BL/6J
background as previously described (Moran et al., 2011). Nur77-GFP mice were provided by Prof. Graham Anderson, University of
Birmingham.
OTI Mice
OTI mice expressing the ab TCR (Va2, Vb5) of the OVA257-264-specific CTL clone 149.42 as previously described (Hogquist et al.,
1994). OTI mice were purchased from Charles River Laboratories.
Breeding
Nr4a3-Tocky Tg4 Tiger mice were used as the F1 generation by crossing Nr4a3-Tocky mice with Tg4 IL-10-GFP Tiger (Burton et al.,
2014), which were provided by Prof. David Wraith, University of Birmingham, UK. Nr4a3-Tocky Great-Smart17A were initially bred to
homozygous OT1mice to generate F1 OT1Nr4a3-Tocky Great Smart-17Amice. Nr4a1-GFPmice were used alone or bred to Nr4a3-
Tocky mice to generate Nr4a1-GFP Nr4a3-Tocky. Nr4a3-Tocky zygosity was determined based on mendelian inheritance or by
phenotype of Nr4a3-Timer expression by flow cytometry.
METHOD DETAILS
In Vitro Cultures
Single cell suspensions of splenocytes from Nr4a3-Tocky Tg4 Tiger and OTI Nr4a3-Tocky mice were generated by forcing organs
through 70-mm cell strainers (Corning). For spleens, a red blood cell (RBC) lysis stage was performed (Invitrogen) according to manu-
facturer’s instructions. Cells were washed once and cultured at 1 3 106 cells per well on 96-well U-bottom plates (Corning) with or
without the presence of peptides or anti-CD3 (145-2C11, BioLegend) in a final volume of 200 ml RPMI1640 + L-glutamine (GIBCO) con-
taining 10% FCS and 1% penicillin/streptomycin (Life Technologies). Inhibitors were dissolved in DMSO. The following inhibitors were
dissolved in DMSO (Sigma) and used: Cyclosporin A (Cambridge Bioscience, 1 mMor as stated), FK506 (Cayman Chemical Company,
1 mM), PD0325901 (Cambridge Bioscience, 5 mM), PP2 (Sigma, 10 mM) and DMSO (Sigma, 0.1%). In experiments were inhibitors were
used, cells were pre-incubated with inhibitors at indicated doses for 30 minutes unless otherwise specified. For Tg4 stimulation 10 mM
of MBP Ac1-9[4Y] peptide was used, for OTI stimulation 1 mM peptide OVA257-264 (N4 = SIINFELK, Q4 = SIIQFEKL4, V4 = SIIVFEKL
variants as indicated) was used, unless stated. For soluble anti-CD3 mediated stimulation, 5 mg/ml soluble anti-CD3 was used. Cells
were incubated at 37C and 5% CO2 and analyzed at the indicated time points for RNA expression or flow cytometric analysis. For
termination of TCR signal studies in Figures 5D–5F, splenocytes from Nr4a1-GFP Nr4a3-Tocky mice were cultured for 4 hrs with 5
mg/ml anti-CD3. At 2.5-, 5-, 10-, 15-, 30-, 60-, 120-minutes PP2 (Sigma) was added at a final concentration of 10 mM. Cells remained
in the incubator until 240 mins from addition of anti-CD3 before harvesting for analysis of Nr4a1-GFP and Nr4a3-Blue expression.Cell Reports 33, 108328, November 3, 2020 e3
Report
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For analysis of thymus and splenic lymphocytes single cell suspensions were prepared as described above. For analysis of bone
marrow B cells, femurs were flushed with media and then RBC lysis performed before staining for flow cytometric analysis. Cells
were washed once and stained in 96-well U-bottom plates (Corning). Analysis was performed on a BD LSR Fortessa X-20 instrument.
The blue form of the Timer protein was detected in the blue (450/40 nm) channel excited off the 405 nm laser. The red form of the
Timer protein was detected in the mCherry (610/20) channel excited off the 561 nm laser. A fixable eFluor 780-flurescent viability
dye (eBioscience) was used for all experiments. The following antibodies were used: anti-CD4 AF700, anti-TCRb AF700, anti-
CD69 APC, anti-CD8 AF700, anti TCR Va2 PerCP/Cyanine5.5, anti-TCR Vb5.1/5.2 APC, Streptavidin BV711, anti-IgM PE-Cy7,
and anti-CD25 PerCP/Cy5.5 (all from BioLegend). Anti-IgD APC was from Invitrogen. Anti-CD23 PE-Cy7 and anti-TCRvb8.1/8.2
PerCP-eFluor710 were from ThermoFisher. Anti-CD19 BUV737, anti-CD4 BUV737, anti-B220 PerCP-Cy5.5, anti-CD21 APC, anti-
CD43 Biotin, anti-TCRvb8.1/8.2 BUV395 and anti-CD8 BUV395 were all from BD Biosciences.
In Vivo Immunisation
Tg4 Nr4a3-Tocky mice were immunized with 80 mg of MBP Ac1-9[4Y], AcASQYRPSQR, peptide or vehicle control (PBS) via sub-
cutaneous injection. 4 hours later, mice were culled and the thymus was removed for flow cytometric analysis.
qPCR analysis
Following in vitro cultures, RNA was extracted using RNeasy mini kit (QIAGEN) according to manufacturer’s instructions. cDNA was
generated using random hexamers (ThermoFisher) and Superscript IV reverse transcriptase (ThermoFisher) according to manufac-
turer’s instructions. mRNA expression was quantified using PowerUp SYBR green (ThermoFisher) and normalized to housekeeping
geneHprtusing 7900HTsequencedetection systemorAppliedBiosystemsAB7500 system. Fold change in expressionwas calculated
using the delta-deltaCtmethod. Primer sequences:Hprt for: AGCCTAAGATGAGCGCAAGT rev: TTACTAGGCAGATGGCCACA;Nr4a1
for: TGTGAGGGCTGCAAGGGCTTC rev: AAGCGGCAGAACTGGCAGCGG; Nr4a2 for: CTGTGCGCTGTTTGCGGTGAC rev: CGGCG
CTTGTCCACTGGGCAG, Nr4a3 for: AGGGCTTCTTCAAGAGAACGG rev: CCATCCCGACACTGAGACAC.
In silico ChIP-Seq
Processed bigwig data files deposited in GEO: GSE64409 (Martinez et al., 2015) were downloaded and hosted in CyVerse Discovery
Environment (https://de.cyverse.org/de) and then mapped against the mm9 genome using the UCSC genome browser. These files
contain analysis of NFAT1 ChIP-Seq in CD8 T cells from WT and NFAT1KO mice either unstimulated or stimulated with PMA and
Ionomycin as described in Martinez et al. (2015).
RNaseq analysis
Log2 fold change estimates of Nr4a1, Nr4a2, Nr4a3 and Cd69 expression was extracted from DESeq data deposited in GEO:
GSE64409 (Martinez et al., 2015) for CD4+ or CD8+ T cells either transfected with mock vector or CA-RIT-NFAT1.
CD4 and CD8 purification
Naive CD4 or bulk CD8 T cell populations were negatively selected using MoJo naive murine CD4 T cell isolation kit (BioLegend) or
murine CD8 T cell isolation kit (BioLegend) by immunomagnetic selection according to the manufacturer’s instructions.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed on Prism 7 or 8 software (GraphPad). For comparison of more than two means a one-way ANOVA
with Turkey’s multiple comparisons test was used. For comparison of more than two means over time, a two-way ANOVA with
Tukey’s multiple comparison’s test was used. Curve fit analysis using non-linear fitting using the normalized response and slope
function on prism 8 software. Variance is reported as mean ± SEM unless otherwise stated. P values that are indicated graphically
represent: *p = < 0.05, **p < 0.01, ***p < 0.001, ****p = < 0.0001. N values can be found within the figure legends and indicate number
of animals. Adjusted p values for analysis of RNA-seq data deposited by Martinez et al. (2015) were extracted from the DESeq anal-
ysis provided by the reference GEO: GSE64409.e4 Cell Reports 33, 108328, November 3, 2020
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Live cells CD4SP CD4SPVb8+
Live cells CD8SP CD8SPVb5+Va2+
Supplementary Figure 1: Analysis of Tg4 Nr4a3-Tocky and OTI Nr4a3-Tocky mice
(related to Figure 1)
(A) Nr4a3-Tocky mice were crossed with Tg4 Tiger mice to generate Tg4 Tiger Nr4a3-Tocky
mice, which are specific for myelin basic protein-derived peptides. Thymus (top) and spleen
(bottom) were analysed for CD4 vs. CD8 expression within live lymphocytes (left), CD4 vs.
TCRVβ8.1/8.2 (middle) gated on CD4SP cells, and Nr4a3-Timer Blue vs Nr4a3-Timer Red in
CD4SPVβ8.1/8.2+ T cells. (B) Nr4a3-Tocky Great Smart-17A mice were bred with OTI TCR
transgenic mice, which are specific for ova peptide. Thymus (top) and spleen (bottom) were
analysed for CD4 vs CD8 expression within live lymphocytes (left), TCRVβ5.1/5.2 vs TCRVα2
















































































































Supplementary Figure 2: Nr4a receptor expression in purified T cell subsets mirrors
responses of bulk splenocyte populations to TCR signalling pathways (related to
Figure 2)
(A) CD8+ T cells from OTI Nr4a3-Tocky mice were isolated by immunomagnetic selection,
purity of a representative isolation is shown gated on live lymphocytes. (B) OTI Nr4a3-Tocky
CD8+ T cells were stimulated with 1µM ova peptide for two hours in the presence of DMSO,
10µM PP2, 1µM Cyclosporin A (CsA), 5µM PD0325901 (PD) MEK inhibitor or 1µM
Cyclosporin A (CsA)+5µM PD0325901 (PD) MEK inhibitor before RNA extraction. Transcript
levels of Nr4a1, Nr4a2 and Nr4a3 were measured by qPCR and fold change in expression
calculated based on unstimulated controls. n=3, bars represent mean±SEM. Statistical
analysis by one-way Anova with Tukey’s multiple comparisons test. (C) Naïve CD4 (left) or
bulk CD8 (right) T cells were isolated by immunomagnetic selection from spleens of Nur77-
GFP Nr4a3-Tocky mice, representative purity plots based on CD4 and CD8 expression are
shown, hgated on live lymphocyte populations. (D) T cell populations were stimulated with
5µg/ml soluble anti-CD3 for six hours in the presence of 0.1% DMSO, 10µM PP2, 1µM
Cyclosporin A (CsA), 5µM PD0325901 (PD) MEK inhibitor or 1µM Cyclosporin A (CsA)+5µM
PD0325901 (PD) MEK inhibitor. Nr4a1-GFP levels in CD4+ (left) or CD8+ right T cells was

















































Supplementary Figure 3: Partial quenching of Nr4a3-Tocky expression when crossed
with Nr4a1-GFP line (related to Figure 3)
(A) Nr4a1-GFP Nr4a3-Tocky mice were generated with either heterozygous or homozygous
BAC genetic status. CD4SP and CD4SP CD25+ T cells within the thymus were compared for
Nr4a3-Blue vs. Nr4a3-Red expression. (B) Histogram overlays showing Nr4a3-Red (top) or












Supplementary Figure 4: Peptide administration activates Nr4a3 expression in
developing thymocytes (related to Figure 3)
Tg4 Nr4a3-Tocky mice were immunised with 80µg of MBP [4Y] peptide or vehicle control
(PBS) and thymus removed 4hrs later and TCRblo and TCRbhi DP and CD4SP subsets














































Supplementary Figure 5: Nr4a1 and Nr4a3 expression patterns during B cell
development (related to Figure 3)
(A) Bone marrow from Nr4a1-GFP Nr4a3-Tocky mice was analysed for expression of Nr4a1-
GFP and Nr4a3-Timer blue and Nr4a3-Timer Red expression within live B220+CD43- B cells.
Gating on pre-B cells (B220+CD43-IgM-IgD-), immature (B220+CD43-IgM+IgD-) and mature B
cells (B220+CD43-IgM+IgD+) (B) Splenic B cell from Nr4a1-GFP Nr4a3-Tocky mice (gated on
B220+CD19+) were divided into follicular (FB, CD21+CD23-) and marginal zone (MZB,
CD21+CD23+) subsets and analysed for expression of Nr4a1-GFP and Nr4a3-Timer Blue and
Nr4a3-Timer Red expression by flow cytometry. Data are representative of two independent
experiments.
